1,226 reports of this reaction
3.0% of all MOXIFLOXACIN reports
#3 most reported adverse reaction
DYSPNOEA is the #3 most commonly reported adverse reaction for MOXIFLOXACIN, manufactured by Lifestar Pharma LLC. There are 1,226 FDA adverse event reports linking MOXIFLOXACIN to DYSPNOEA. This represents approximately 3.0% of all 40,887 adverse event reports for this drug.
Patients taking MOXIFLOXACIN who experience dyspnoea should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DYSPNOEA is a less commonly reported adverse event for MOXIFLOXACIN, but still significant enough to appear in the safety profile.
In addition to dyspnoea, the following adverse reactions have been reported for MOXIFLOXACIN:
The following drugs have also been linked to dyspnoea in FDA adverse event reports:
DYSPNOEA has been reported as an adverse event in 1,226 FDA reports for MOXIFLOXACIN. This does not prove causation, but indicates an association observed in post-market surveillance data.
DYSPNOEA accounts for approximately 3.0% of all adverse event reports for MOXIFLOXACIN, making it one of the most commonly reported side effect.
If you experience dyspnoea while taking MOXIFLOXACIN, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.